Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.
Gianluigi RedaBruno FattizzoRamona CassinVeronica MattielloTatiana TonellaDiana GiannarelliFerdinando MassariAgostino CortelezziPublished in: Journal of hematology & oncology (2018)
Our data show that echocardiography is a highly informative and reproducible tool that should be included in pre-treatment workup for patients who are candidates for ibrutinib therapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- atrial fibrillation
- prognostic factors
- peritoneal dialysis
- heart failure
- computed tomography
- stem cells
- chronic lymphocytic leukemia
- patient reported outcomes
- left ventricular
- mesenchymal stem cells
- electronic health record
- mitral valve
- combination therapy
- replacement therapy